- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Introgen Therapeutics Inc+ Add to Watchlist
INGNQ:US0.0001 USD 0.00000.00%
As of 20:10:00 ET on 08/15/2014.
Company Profile for Introgen Therapeutics Inc (INGNQ)
Introgen Therapeutics, Inc. develops gene therapy products for the treatment of cancer. The Company's lead product candidate combines the p53 gene, a tumor suppressor gene, with a gene delivery system that it has developed and tested. Introgen is developing cancer therapies which are based on restoring normal cellular function through gene therapy.
Introgen Therapeutics Inc
Key Executives for Introgen Therapeutics Inc (INGNQ)
|Kerstin B MenanderVP:Clinical Development||Rodney VarnerSecretary|